Robert James Finlayson

4.1k citations
74 papers · 3.3k · 3 hit papers · h-index 28

Impact in

  • Virology top 0.5%
    • HIV Research and Treatment
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment

Papers in

    • HIV Research and Treatment 17
    • HIV/AIDS Research and Interventions 13
    • HIV/AIDS drug development and treatment 10

Robert James Finlayson

73 papers receiving 3.1k citations

Robert James Finlayson's Hit Papers

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 2018 · 313 citations
3130+13+27Years since publication100200300400500

Peers

Robert James Finlayson
Comparison fields: 5 of 128
  • Virology 1.1k
  • Infectious Diseases 1.4k
  • Emergency Medicine 270
  • Hepatology 178
  • Epidemiology 749
Replace Arye Rubinstein with:
Arye Rubinstein United States
Ivano Mezzaroma Italy
Christine Jacomet France
Jan Gerstoft Denmark
Harry E. Prince United States
Christophe Piketty France
Luca Meroni Italy
Jason F. Okulicz United States
Normand Lapointe Canada
Manfred Dietrich Germany
Robert James Finlayson relative to Arye Rubinstein United States Arye Rubinstein's profile →
Citations per field
00.5×2×3×3.8×
Arye Rubinstein · 1×
Citations per year

Countries citing papers authored by Robert James Finlayson

Since Specialization
Citations

This map shows the geographic impact of Robert James Finlayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert James Finlayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert James Finlayson more than expected).

Fields of papers citing papers by Robert James Finlayson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert James Finlayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert James Finlayson. The network helps show where Robert James Finlayson may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert James Finlayson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert James Finlayson Line = papers co-authored together Robert James Finlayson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
ACUTE AIDS RETROVIRUS INFECTION
Hit paper breakdown →
1985557
2
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Hit paper breakdown →
2018313
3
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study
Hit paper breakdown →
2018295
4 2009212
5 2002146
6 2018125
7 2000121
8 1996102
9 202179
10 200574
11 200674
12 201268
13 201367
14 201959
15 196551
16 201251
17 202049
18 201748
19 196245
20 200744

About Robert James Finlayson

Robert James Finlayson is a scholar working on Virology, Infectious Diseases, Hepatology, Emergency Medicine and Immunology, having authored 74 papers that have together received 3.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS Research and Interventions (13 papers), Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (10 papers), HIV-related health complications and treatments (8 papers), Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (5 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.4k citations), Emergency Medicine (270 citations), Hepatology (178 citations) and Epidemiology (749 citations). Robert James Finlayson has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Julian Gold, Basil J Donovan, David A. Cooper, D. A. Cooper, John J. Zaunders, Mark Theo Bloch, Don E. Smith, John Martin Kaldor, Gilbert R. Kaufmann and Anthony D. Kelleher. Their work appears in journals such as Clinical Infectious Diseases, AIDS, The Lancet HIV, Journal of Hepatology and The Medical Journal of Australia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact